Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Gade

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Cancer Cell|February 16, 2013
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancerJoachim Weischenfeldt, Ronald Simon, Lars Feuerbach, et al.
Pageof 3